BioVersys AG is a multi-asset, clinical stage biopharmaceutical company focused on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (“MDR”) bacteria. Derived from the company’s two internal technology platforms (TRIC and Ansamycin Chemistry), candidates are designed and developed to overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria towards the identification of new treatment options in the antimicrobial and microbiome fields. This enables BioVersys to address the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. The company’s most advanced research and development programs address nosocomial infections of Acinetobacter baumannii (BV100, Phase 2), and tuberculosis (alpibectir, Phase 2a, in collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille, France). BioVersys is located in the biotech hub of Basel, Switzerland. | BioVersys AG is a multi-asset, clinical stage biopharmaceutical company focused on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (“MDR”) bacteria. Derived from the company’s two internal technology platforms (TRIC and Ansamycin Chemistry), candidates are designed and developed to overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria towards the identification of new treatment options in the antimicrobial and microbiome fields. This enables BioVersys to address the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. The company’s most advanced research and development programs address nosocomial infections of Acinetobacter baumannii (BV100, Phase 3 ready), and tuberculosis (alpibectir, Phase 2a, in collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille, France). BioVersys is located in the biotech hub of Basel, Switzerland.
Biopôle SA
Biopôle Lausanne is one of the largest life sciences campus in Europe, hosting a vibrant community of world-renowned industry players and research institutes, based in Lausanne, Switzerland (www.biopole.ch). It offers a world-class combination of modern infrastructure (134,000 sqm of office/lab space), added value services, an extensive network, innovation and funding programmes, and unparalleled community engagement where members can thrive and bring science to life. Biopôle houses 130+ life sciences companies, including 50 biotech/pharma such as Ferring, Roche, Ichnos, etc. and world-class research organizations (Lausanne University Hospital (CHUV), University of Lausanne (UNIL), the Ludwig Institute for Cancer Research etc.), a life science incubator (StartLab), ready-to-move-in private labs (Superlab), a Digital Health Hub (DH2) enabling the emergence of outstanding innovation for the betterment of healthcare. Join Biopôle.
Biognosys
Biognosys is a leading contract research organization (CRO) specializing in proteomics services for early-stage R&D through clinical trial biomarker monitoring. Partnering with the most innovative biotech and pharmaceutical companies worldwide, Biognosys utilizes unique, patented technologies and high-resolution mass spectrometry to quantify thousands of proteins with unmatched precision, depth, and throughput. With laboratories near Zurich, Switzerland and Boston, Massachusetts, Biognosys combines scientific expertise and next-generation proteomics to accelerate drug discovery and development, and supports translational and preclinical research, and clinical trials for precision medicine. Learn more at www.biognosys.com
Bioengineering AG
Bioengineering AG is an indipendent and autonomous company that has been successfully turning customers’ ideas into reality since 1972. We offer comprehensive solutions in the areas of Engineering & Design, Services, Plants, Bioprocess Control, Lab & Pilot, and Components. We build plants for the production of vaccines, biosimilars, starter cultures and other products and develop automation solutions and components for controlling and monitoring the plants. Over 50 years of experience in plant construction and our innovative strength enable us to successfully realise even the most complex plants. | Bioengineering AG is an independent and autonomous company that has been successfully turning customers’ ideas into reality since 1972. We offer comprehensive solutions in the areas of Engineering & Design, Services, Plants, Bioprocess Control, Lab & Pilot, and Components. We build plants for the production of vaccines, biosimilars, starter cultures and other products and develop automation solutions and components for controlling and monitoring the plants. Over 50 years of experience in plant construction and our innovative strength enable us to successfully realise even the most complex plants. | Our fields of study may be diverse, but we are all engineers at heart. And citizens of the world. Here at Bioengineering, we work for those creating and making discoveries in laboratories and production facilities around the world. What unites us with them is a certain mindset: excellence. That’s what we fly the flag for, regardless of nationality. Our claim to excellence underlines our position as an intelligent and reliable partner who, with their bioreactors and fermentors, works in collaboration with the best companies in the world: inspiring excellence.
BioAlps Association
Founded in 2003, BioAlps Association empowers the Swiss Health Valley and represents Western Switzerland Life Sciences ecosystem (medtech, biotech, pharma, digital health, nutrition, cosmetics, etc.). The organisation is supported by 7 cantons: Bern, Fribourg, Vaud, Neuchâtel, Geneva, Valais and Jura, by the Swiss State Secretariat for Economic Affairs (SECO) and by 15 academic institutions. It offers a dynamic network in medtech, biotech, pharma and digital health, and an innovative and supportive environment. With more than 1 000 companies, 60 Research & Academic institutions, over 60 public institutions and innovation parks, 3 university hospitals, more than 35 000 jobs, the region is the most diversified life sciences ecosystem in Europe. Startup companies and large multinationals are concentrated within a small, attractive geographic area with great infrastructure. BioAlps Association: – Offers the most updated database of life sciences actors in Western Switzerland, and offers a close and inclusive biotech, medtech and digital health community – Gathers and disseminates all the key information, News, Events, Business Opportunities, of the Swiss Health Valley – Organises networking events : 4à6, Deep Dives, Innovators Connect, BioAlps Networking Day, etc. – Promotes and strengthens synergies among its members in the academic and private sectors – Fully supports the transfer of technologies and competencies from academic to industrial settings – Develops the exchange of information and resources between scientists, the financial community and government representatives – Establishes relationships with similar initiatives in life sciences at the local and national levels – Provides a communication network throughout Switzerland and internationally | BioAlps is a diversified life sciences cluster representing over 1400 Western Switzerland research and industry organisations in the fields of biotech, medtech, pharma, e-health, nutrition, and cosmetics. Supported by 15 academic institutions, 6 cantons (states) and the Swiss State Secretariat for Economic Affairs, BioAlps empowers the Swiss Health Valley by providing opportunities to network during events organised and supported by the Association in Switzerland and internationally. | x
BioArk SA
BioArk is The life sciences community of the canton of Valais in Switzerland! Homeland of the Pharma and Biotech manufacturing in Switzerland, BioArk gather an ecosystem of large multinationals, SMEs and start-up making our region the place to be in center of Europe. BioArk is also able to propose a technological park of 5 buidlings. With its specialised facilities and network of expertise, it enables SMEs and start-ups working in the fields of biotechnology and diagnostics to realise their business opportunities. So it is the ideal place for developing your business or for transforming your project into an industrial and commercial reality | The Valais provides a renowned and attractive ecosystem for pharmaceutical and biopharmaceutical manufacturing, making it a prominent hub in the industry. The Valais is a stimulating environment with a complete value chain, from cutting-edge research to high-quality production facilities. Thanks to its specialized infrastructure and network of skills, BioArk enables SMEs and start-ups active in biotechnology and diagnostics to successfully realize their business opportunities. They are therefore ideal locations for developing your business or transforming your project into an industrial and commercial reality. | BioArk – Empowering Biotech Innovation Through Infrastructure, Expertise, and Community BioArk is a leading life sciences technology park located in Valais, Switzerland, with campuses in Monthey and Visp. Developed and managed by The Ark Foundation, BioArk provides state-of-the-art infrastructure, specialized support services, and, most importantly, access to a dynamic and collaborative community of innovators across the life sciences value chain. BioArk is more than just a workspace—it is a growth platform where start-ups, SMEs, and established companies evolve in a supportive, high-performance ecosystem. Whether in biotech, diagnostics, medtech, or industrial biomanufacturing, BioArk helps companies transform ideas into scalable innovations and successful ventures.
BigOmics Analytics
BigOmics Analytics is a Swiss-based company that expedites tertiary single- and multi-omics data analysis through Omics Playground, a collaborative data discovery platform that enables scientists to scale their analysis, gain real-time insights, and produce reproducible results. With more than 18 analysis modules and 150 interactive plots, Omics Playground applies best-in-class methods and algorithms at every step to ensure robust and reliable outcomes.
Better Cotton Initiative
Better Cotton is the world’s leading sustainability initiative for cotton, working to help cotton communities survive and thrive while protecting and restoring the environment.
BERHALTER Swiss Die-Cutting
With more than 60 years of experience, BERHALTER® Swiss Die-Cutting became the leader in manufacturing high precision punching tools and efficient die–cutting machines. The lids and labels, produced by BERHALTER® machines and tools, are mostly used in the food, beverage and pharmaceutical industries.Increasing of quality, efficiency and productivity with INNOVATION by die–cuttingCUTcontrol™- IIoT Digital Service Platform WEBinspect™- 100 % web surface inspection systemPRINTinspect™- 100 % print inspection systemWEBslitter™- production enhancement systemREELsplicer™- in-register reel changing and splicing systemPRElaser™- laser system for additional functions as perforationSMARTembosser™ – patented embossing system for rim-embossingLABEL-light™ – patented low cost tool for In-Mold-Label applicationBEAMstack™- first fully automatic packing system worldwide | BERHALTER Swiss Die-Cutting – Precision. Innovation. Complete Die-Cutting Solutions.BERHALTER Swiss Die-Cutting is a Swiss manufacturer of high-performance flatbed die-cutting machines, high-precision die-cutting tools, and complete die-cutting equipment. With over 65 years of engineering excellence, BERHALTER delivers fully integrated systems that combine precision, automation, and efficiency — trusted by leading global converters, co-packers, and brand owners.Headquartered in Widnau, Switzerland, BERHALTER Swiss Die-Cutting serves industries including food & beverage, dairy, personal care, pharmaceutical, and labeling. Our machines are designed for producing aluminum lids, deep-drawn packaging, paper labels, and IML labels — achieving flawless cut quality at maximum throughput. Full-System Manufacturing: Machines, Tools & EquipmentUnlike many in the market, BERHALTER Swiss Die-Cutting offers a complete portfolio — from high-performance machines to perfectly matched cutting tools and intelligent accessories. This in-house synergy allows seamless production, reduced material waste, and minimized downtime.Our Swiss Tooling Division manufactures state-of-the-art punching tools optimized for quick changeovers, maximum durability, and zero-defect output. We deliver a full equipment ecosystem tailored to your specific material and product requirements. Product InnovationsSwiss Die-Cutter™ B4 & B6 – Advanced flatbed die-cutting systems offering high-speed performance up to 500 strokes per minute, modularity, and easy automation integration.BEAMstack™ – Automated robot stacking solution for efficient downstream handling.CUTcontrol™ – IIoT- smart digital service platform providing real-time performance tracking, remote diagnostics, and data-driven process control. Global Reach. Swiss Reliability.With installations in over 60 countries, BERHALTER systems are built for global productivity. Our worldwide service network ensures expert support, rapid spare part delivery, and operator training — wherever you are. Made in Switzerland. Driven by Innovation.Family-owned since 1960, BERHALTER stands for engineering precision, high automation standards, and continuous technological innovation. From machine to tool, from software to service — we are your full-solution partner for industrial die-cutting. Visit us at Booth SU-37044 at Pack Expo Las Vegas 2025 – and experience the future of precision die-cutting.